| References |
|
|
Baba Y and
Uitti RJ
(2005)
Fragile X-associated tremor/ataxia syndrome and movements disorders.
Current Opinion in Neurology
18:
393.
|
|
|
Brown FR 3rd,
Voigt R,
Singh AK and
Singh I
(1993)
Peroxisomal disorders. Neurodevelopmental and biochemical aspects.
American Journal of Diseases of Children
147:
617.
|
|
|
Dressler D and
Benecke R
(2005)
Diagnosis and management of acute movement disorders.
Journal of Neurology
252:
1299.
|
|
|
Frappart PO and
McKinnon PJ
(2006)
Ataxia-telangiectasia and related diseases.
Neuromolecular Medicine
8:
495.
|
|
|
Gabsi S,
Gouider-Khouja N,
Belal S et al.
(2001)
Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency.
European Journal of Neurology
8:
477.
|
|
|
Gironi M,
Lamperti C,
Nemni R et al.
(2004)
Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency.
Neurology
62:
818.
|
|
|
Gros-Louis F,
Dupré N,
Dion P et al.
(2007)
Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia.
Nature Genetics
39(1):
8085.
|
|
|
Horvath R,
Hudson G,
Ferrari G et al.
(2006)
Phenotypic spectrum associated with mutations of the mitochondrial polymerase (gamma) gene 10.1093/brain/awl088.
Brain
129:
1674.
|
|
|
Jacquemont S,
Hagerman RJ,
Leehey MA et al.
(2004)
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
JAMA
291:
460.
|
|
|
Jonas AJ and
Butler IJ
(1989)
Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester.
Journal of Clinical Investigation
84:
200.
|
|
|
Lamperti C,
Naini A,
Hirano M et al.
(2003)
Cerebellar ataxia and coenzyme Q10 deficiency.
Neurology
60:
1206.
|
|
|
Le Ber I,
Bouslam N,
Rivaud-Pechoux S et al.
(2004)
Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.
Brain
127:
759.
|
|
|
Le Ber I,
Dubourg O,
Benoist J-F et al.
(2007)
Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1 10.1212/01.wnl.0000252366.10731.43.
Neurology
68:
295.
|
|
|
Le Ber I,
Moreira MC,
Rivaud-Pechoux S et al.
(2003)
Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies.
Brain
126:
2761.
|
|
|
Moghadasian MH
(2004)
Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds.
Clinical and Investigative Medicine
27:
42.
|
|
|
Moreira MC,
Klur S,
Watanabe M et al.
(2004)
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
Nature Genetics
36:
225.
|
|
|
Mukherji M,
Chien W,
Kershaw NJ et al.
(2001)
Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease.
Human Molecular Genetics
10:
1971.
|
|
|
Ogawa M
(2004)
Pharmacological treatments of cerebellar ataxia.
Cerebellum
3:
107.
|
|
|
Quinzii C,
Naini A,
Salviati L et al.
(2006)
A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.
American Journal of Human Genetics
78:
345.
|
|
|
Roy CN and
Andrews NC
(2001)
Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers 10.1093/hmg/10.20.2181.
Human Molecular Genetics
10:
2181.
|
|
|
Strupp M,
Kalla R,
Dichgans M et al.
(2004)
Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
Neurology
62:
1623.
|
|
|
Zeviani M and
Di Donato S
(2004)
Mitochondrial disorders.
Brain
127:
2153.
|
| Further Reading |
|
|
Abele M,
Weller M,
Mescheriakov S et al.
(1999)
Cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
Neurology
52:
857.
|
|
|
Allen RK,
Sellars RE and
Sandstrom PA
(2003)
A prospective study of 32 patients with neurosarcoidosis.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases
20:
118.
|
|
|
Bataller L and
Dalmau J
(2003)
Paraneoplastic neurologic syndromes.
Neurologic Clinic
21:
221.
|
|
|
Bushara KO,
Goebel SU,
Shill H et al.
(2001)
Gluten sensitivity in sporadic and hereditary cerebellar ataxia.
Annals of Neurology
49:
540.
|
|
|
Dalmau J,
Graus F,
Rosenblum MK and
Posner JB
(1992)
Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients.
Medicine (Baltimore)
71:
59.
|
|
|
Di Prospero NA and
Fischbeck KH
(2005)
Therapeutics development for triplet repeat expansion diseases.
Nature Reviews. Genetics
6:
756.
|
|
|
Evaluation and management of intracranial mass lesions in AIDS
(1998)
Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology
50:
21.
|
|
|
Fisher M
(1956)
An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia).
New England Journal of Medicine
255:
57.
|
|
|
Hadjivassiliou M,
Davies-Jones GA,
Sanders DS and
Grunewald RA
(2003)
Dietary treatment of gluten ataxia.
Journal of Neurology, Neurosurgery, and Psychiatry
74:
1221.
|
|
|
Hadjivassiliou M,
Grunewald RA,
Chattopadhyay AK et al.
(1998)
Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia.
Lancet
352:
1582.
|
|
|
Hart PE,
Lodi R,
Rajagopalan B et al.
(2005)
Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
Archives of Neurology
62:
621.
|
|
|
Honnorat J,
Saiz A,
Giometto B et al.
(2001)
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Archives of Neurology
58:
225.
|
|
|
Kamm C,
Healy DG,
Quinn NP et al.
(2005)
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group.
Brain
128:
1855.
|
|
|
Kappos L,
Polman CH,
Freedman MS et al.
(2006)
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Neurology
67:
1242.
|
|
|
Kinkel RP,
Kollman C,
O'Connor P et al.
(2006)
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Neurology
66:
678.
|
|
|
Liu GT,
Volpe NJ and
Galetta SL
(1995)
Eye movement disorders.
Current Opinion in Ophthalmology
6:
27.
|
|
|
Marmarou A,
Young HF,
Aygok GA et al.
(2005)
Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients.
Journal of Neurosurgery
102:
987.
|
|
|
Narang HK
(2001)
A critical review of atypical cerebellum-type Creutzfeldt-Jakob disease: its relationship to new variant CJD and bovine spongiform encephalopathy.
Experimental Biology and Medicine (Maywood)
226:
629.
|
|
|
Ravi V and
Rozen TD
(2000)
Acute cerebellitis: MRI findings.
Neurology
54:
213.
|
|
|
Rosenfeld MR,
Eichen JG,
Wade DF et al.
(2001)
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.
Annals of Neurology
50:
339.
|
|
|
Sabater L,
Bataller L,
Carpentier AF et al.
(2006)
Protein kinase C gamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer.
Journal of Neurology, Neurosurgery, and Psychiatry
77:
1359.
|
|
|
Sanchez-Juan P,
Green A,
Ladogana A et al.
(2006)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease 10.1212/01.wnl.0000230159.67128.00.
Neurology
67:
637.
|
|
|
Sawaishi Y and
Takada G
(2002)
Acute cerebellitis.
Cerebellum
1:
223.
|
|
|
Smitt PS,
Kinoshita A,
De Leeuw B et al.
(2000)
Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor 10.1056/NEJM200001063420104.
New England Journal of Medicine
342:
21.
|
|
|
book
Timmann D
(2003)
"Coordination and ataxia".
In: Goetz C (ed.)
Textbook of Clinical Neurology.
St Louis, MO: Saunders Press.
|
|
|
Warrick JM,
Morabito LM,
Bilen J et al.
(2005)
Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.
Molecular Cell
18:
37.
|